Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H17F4NO3S2 |
| Molecular Weight | 471.488 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CSC2=CC(C)=C(OCC(O)=O)C=C2)SC(=N1)C3=CC=C(C(F)=C3)C(F)(F)F
InChI
InChIKey=HWVNEWGKWRGSRK-UHFFFAOYSA-N
InChI=1S/C21H17F4NO3S2/c1-11-7-14(4-6-17(11)29-9-19(27)28)30-10-18-12(2)26-20(31-18)13-3-5-15(16(22)8-13)21(23,24)25/h3-8H,9-10H2,1-2H3,(H,27,28)
| Molecular Formula | C21H17F4NO3S2 |
| Molecular Weight | 471.488 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12699745 | https://www.ncbi.nlm.nih.gov/pubmed/25592770Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26508837 | https://www.ncbi.nlm.nih.gov/pubmed/21270242
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12699745 | https://www.ncbi.nlm.nih.gov/pubmed/25592770
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26508837 | https://www.ncbi.nlm.nih.gov/pubmed/21270242
GW0742, also known as GW610742, is a potent and highly selective PPARβ/δ agonist, with IC50 of 1 nM, with 1000-fold selectivity over hPPARα and hPPARγ. GW0742 treatment has a prominent anti-inflammatory effect in 5XFAD mice and suggests that PPARδ agonists may have therapeutic utility in treating AD. GW0742 has the ability to improve glucose homeostasis in diabetic rats through activation of PPAR-δ. Therefore, PPAR-δ is a good target for the development of antidiabetic drugs in the future.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3979 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12699745 |
1.0 nM [EC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice. | 2016-06 |
|
| Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation. | 2015-01-16 |
|
| Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals. | 2015 |
|
| Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity. | 2003-05-05 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18622687
Mice: GW0742 (30 mg/kg) significantly decreases protein and mRNA levels of the pro-inflammatory cytokines IL-6, IL-1beta and TNFalpha in bronchial alveolar lavage fluid of mice.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12699745
GW0742 (0.2 uM and 1 uM) treatment results in significant increases in reporter activity of PPARβ/δ in N/TERT-1 keratinocytes. GW0742 (1 uM) results in significant inhibition in the average number of N/TERT-1 keratinocytes. GW0742 (1 uM) results in an increase in the number of cells in the G1 phase and a decrease in the number of cells in the S phase.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:47:20 GMT 2025
by
admin
on
Mon Mar 31 22:47:20 GMT 2025
|
| Record UNII |
4PZK9FJC4Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GW0742
Created by
admin on Mon Mar 31 22:47:20 GMT 2025 , Edited by admin on Mon Mar 31 22:47:20 GMT 2025
|
PRIMARY | |||
|
4PZK9FJC4Z
Created by
admin on Mon Mar 31 22:47:20 GMT 2025 , Edited by admin on Mon Mar 31 22:47:20 GMT 2025
|
PRIMARY | |||
|
9934458
Created by
admin on Mon Mar 31 22:47:20 GMT 2025 , Edited by admin on Mon Mar 31 22:47:20 GMT 2025
|
PRIMARY | |||
|
DTXSID9040760
Created by
admin on Mon Mar 31 22:47:20 GMT 2025 , Edited by admin on Mon Mar 31 22:47:20 GMT 2025
|
PRIMARY | |||
|
317318-84-6
Created by
admin on Mon Mar 31 22:47:20 GMT 2025 , Edited by admin on Mon Mar 31 22:47:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|